AstraZeneca Pharma - we had a pilot position @1940 and we added more today@2136
3 yr average sales growth - 4%
3 yr average profit growth - 120%
3 yr average margin growth - 200%
The sales growth is not very impressive however the company was making losses from 2013-2015 and it has turned around since 2016. We will be watching the upcoming quarters for a further cue in the improvement of sales and we will also look for guidance from the annual reports.
3 yr average sales growth - 4%
3 yr average profit growth - 120%
3 yr average margin growth - 200%
The sales growth is not very impressive however the company was making losses from 2013-2015 and it has turned around since 2016. We will be watching the upcoming quarters for a further cue in the improvement of sales and we will also look for guidance from the annual reports.
Value doesn't move stock prices, people do by placing buy orders. Value is only part of the equation. Ultimately, you need demand - Mark Minervini
Exención de responsabilidad
La información y las publicaciones no constituyen, ni deben considerarse como asesoramiento o recomendaciones financieras, de inversión, de trading o de otro tipo proporcionadas o respaldadas por TradingView. Más información en Condiciones de uso.
Value doesn't move stock prices, people do by placing buy orders. Value is only part of the equation. Ultimately, you need demand - Mark Minervini
Exención de responsabilidad
La información y las publicaciones no constituyen, ni deben considerarse como asesoramiento o recomendaciones financieras, de inversión, de trading o de otro tipo proporcionadas o respaldadas por TradingView. Más información en Condiciones de uso.